These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 17851543)

  • 1. Emerging roles of proteases in tumour suppression.
    López-Otín C; Matrisian LM
    Nat Rev Cancer; 2007 Oct; 7(10):800-8. PubMed ID: 17851543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineating protease functions during cancer development.
    Affara NI; Andreu P; Coussens LM
    Methods Mol Biol; 2009; 539():1-32. PubMed ID: 19377975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic identification of protease cleavage sites: cell-biological and biomedical applications.
    Shahinian H; Tholen S; Schilling O
    Expert Rev Proteomics; 2013 Oct; 10(5):421-33. PubMed ID: 24117201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function in dipeptidyl peptidase IV and related proteins.
    Gorrell MD; Wang XM; Park J; Ajami K; Yu DM; Knott H; Seth D; McCaughan GW
    Adv Exp Med Biol; 2006; 575():45-54. PubMed ID: 16700507
    [No Abstract]   [Full Text] [Related]  

  • 5. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.
    Olson OC; Joyce JA
    Nat Rev Cancer; 2015 Dec; 15(12):712-29. PubMed ID: 26597527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of fluorescent imaging to investigate pathological protease activity.
    Blum G
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):708-16. PubMed ID: 18729022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-proline-cleaving peptidases having DP IV like enzyme activity. Post-proline peptidases.
    Abbott CA; Yu D; McCaughan GW; Gorrell MD
    Adv Exp Med Biol; 2000; 477():103-9. PubMed ID: 10849735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular proteases as targets for treatment of cancer metastases.
    Lee M; Fridman R; Mobashery S
    Chem Soc Rev; 2004 Sep; 33(7):401-9. PubMed ID: 15354221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane proteases and tetraspanins.
    Yáñez-Mó M; Sánchez-Madrid F; Cabañas C
    Biochem Soc Trans; 2011 Apr; 39(2):541-6. PubMed ID: 21428936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acid proteases from chicken liver. Cooperative hydrolysis of proteins (author's transl)].
    Barceló F; Vives N; Bozal J
    Rev Esp Fisiol; 1980 Jun; 36(2):139-45. PubMed ID: 6996059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal peptidases and glycosidases in rheumatoid arthritis.
    Sohar N; Hammer H; Sohar I
    Biol Chem; 2002 May; 383(5):865-9. PubMed ID: 12108554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: peptidases and peptidase inhibitors in the pathogenesis of diseases. Disturbances in the ubiquitin-mediated proteolytic system. Protease-antiprotease imbalance in inflammatory reactions. Role of cathepsins in tumour progression.
    Bank U; Krüger S; Langner J; Roessner A
    Adv Exp Med Biol; 2000; 477():349-78. PubMed ID: 10849763
    [No Abstract]   [Full Text] [Related]  

  • 13. A fresh prospect of extracellular matrix hydrolytic enzymes and their substrates.
    Roycik MD; Fang X; Sang QX
    Curr Pharm Des; 2009; 15(12):1295-308. PubMed ID: 19355969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kallikrein-related peptidase family: Dysregulation and functions during cancer progression.
    Kryza T; Silva ML; Loessner D; Heuzé-Vourc'h N; Clements JA
    Biochimie; 2016 Mar; 122():283-99. PubMed ID: 26343558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Roles of Protease Inhibitors in Cancer Progression.
    Yang P; Li ZY; Li HQ
    Asian Pac J Cancer Prev; 2015; 16(18):8047-52. PubMed ID: 26745037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interplay between tetraspanins and proteases.
    Yáñez-Mó M; Gutiérrez-López MD; Cabañas C
    Cell Mol Life Sci; 2011 Oct; 68(20):3323-35. PubMed ID: 21687991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular protease changes in acute experimental hypersensitivity pneumonitis.
    Kalnitsky G; Singh H; Kuo T; Ihnen J; Clarke WR; Ratajczak HV; Richerson HB
    Lung; 1982; 160(5):245-56. PubMed ID: 6750259
    [No Abstract]   [Full Text] [Related]  

  • 18. Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease.
    Taggart CC; Greene CM; Carroll TP; O'Neill SJ; McElvaney NG
    Am J Respir Crit Care Med; 2005 May; 171(10):1070-6. PubMed ID: 15695494
    [No Abstract]   [Full Text] [Related]  

  • 19. Protease-activated nanomaterials for targeted cancer theranostics.
    Chan YC; Hsiao M
    Nanomedicine (Lond); 2017 Sep; 12(18):2153-2159. PubMed ID: 28814163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metalloproteinases in melanoma.
    Moro N; Mauch C; Zigrino P
    Eur J Cell Biol; 2014; 93(1-2):23-9. PubMed ID: 24530009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.